Founded in 1998, The CID Group was established by a seasoned and professional team with more than 200 years 

of direct investment experiences. Since inception, the team has been fully committed to carrying out the mission 

of “Integrating Global Resources to Create Synergistic Businesses”. Today, CID has become one of the fastest 

growing Asia-headquartered private equity firms. For more than a decade, CID has been focusing on identifying 

and building top emerging Greater China companies. CID aims to leverage the unique and systematic investment 

platforms built in Shanghai, Beijing, Chongqing, Taipei and the U.S., to provide real operational value-add to 

portfolio companies and thus create more consistent and superior investment returns. CID has delivered more 

than 35% IRR consistently over the past 12 years, and achieved 40 IPOs and 24 M&A/trade sales from more than 

140 investments. With investors including prominent endowments, foundations, pensions, financial institutions 

and worldwide public corporations from United Stated, Europe, Japan, Singapore, Middle East and Taiwan, today 

CID is managing 3 LP funds with over US$1B capital. 


   http://www.cidgroup.com/EN




About
Company Profile
Management Team
Board of Directors
Vision & Mission
Corporate History
Capability
Capability
Advantage
Products
Drug Products
APIs
Intermediates
Fine chemicals
Investors
BAR Capital
Acorn Campus Ventures
CID Group
Orbimed
News
Company News
Media Reports
Publications
Contacts
Location & massage
Career